HMOX1 and acute lymphoblastic leukemia: The aim of this study was to investigate the impact of HMOX1 promoter polymorphisms on long-term clinical outcomes, the prevalence of childhood ALL, and the role of certain polymorphic variants in resistance to chemotherapy.